Vanguard Personalized Indexing Management
PRAX icon

Vanguard Personalized Indexing Management’s Praxis Precision Medicines PRAX Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$392K Sell
1,170
-174
-13% -$55.1K ﹤0.01% 1542
2026
Q1 		$433K Buy
+1,344
New +$416K ﹤0.01% 1389

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Vanguard Personalized Indexing Management's PRAX Position: Q2 2026 in Review

Vanguard Personalized Indexing Management reduced its Praxis Precision Medicines (PRAX) stake by 13% in Q2 2026, selling an estimated $55.1K and leaving 1,170 shares worth $392K. The position accounts for ﹤0.01% of the portfolio, ranked #1542.

Vanguard Personalized Indexing Management first reported a position in PRAX in Q1 2026 and has held it in 2 quarters since. The position peaked at $433K in Q1 2026. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Vanguard Personalized Indexing Management held 1,170 shares of Praxis Precision Medicines worth $392K as of Q2 2026.
  • Vanguard Personalized Indexing Management sold 174 Praxis Precision Medicines shares in Q2 2026, an estimated $55.1K.
  • Praxis Precision Medicines made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #1542 holding.
  • Vanguard Personalized Indexing Management first reported a position in Praxis Precision Medicines in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Personalized Indexing Management's Praxis Precision Medicines position peaked at $433K in Q1 2026.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.